Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

Autor: Jordi Esteve, J. Arias, Cristiane Damas Gil, Miguel A. Sanz, Celina Benavente, Montserrat Arnan, Josep-Maria Ribera, M.E. Amutio, Pau Montesinos, Silvia Negri, Lourdes Escoda, Edo Vellenga, Salut Brunet, Viñas Rubio, José González-Campos, Olga Salamero, Manuel Pérez-Encinas, Alexandra Holowiecka, Teresa Bernal, J. de la Serna, Bob Löwenberg, David Martínez-Cuadrón

Publikováno v: Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Leukemia, 32(1), 21-29. Nature Publishing Group

Treatment outcome in older patients with acute promyelocytic leukemia (APL) is lower compared with younger patients, mainly because of a higher induction death rate and postremission non-relapse mortality (NRM). This prompted us to design a risk-and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ef495d5a505016278e10f76ed577edc
https://doi.org/10.1038/leu.2017.178

Infiltrative cervical lesions causing symptomatic occipital neuralgia

Autor: F Sierra-Hidalgo, J de la Serna, A Morales-Cartagena, Juan Carlos Ruiz, A Martínez-Salio, Jesús Hernández-Gallego

Publikováno v: Cephalalgia. 31:1493-1496

Background: Occipital neuralgia is a well-recognized cause of posterior head and neck pain that may associate mild sensory changes in the cutaneous distribution of the occipital nerves, lacking a recognizable local structural aetiology in most cases.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eff574936769f75ff9537a9cba68c17
https://doi.org/10.1177/0333102411418693

Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS

Autor: M. D. Caballero, Carlos Vallejo, S G Perez, Eulogio Conde, Guillermo Sanz, Jaime Sanz, D Serrano, Arancha Bermúdez, José M. Moraleda, J.J. Lahuerta, J. de la Serna, M. Cabrero, Valle Gomez

Publikováno v: Bone marrow transplantation. 51(7)

The safety and efficacy of a 4-day myeloablative conditioning (MAC) regimen consisting of Bu 3.2 mg/kg and fludarabine 40 mg/m2/day for HLA-identical sibling allogeneic hematopoietic cell transplantation (HCT) in myeloid malignancies was investigated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b820c8a2a8c56a737134e36bfe0e756
https://pubmed.ncbi.nlm.nih.gov/27111045